FOSTER CITY, Calif.--(BUSINESS WIRE)--Entelos, Inc. (LSE:ENTL), a leading life sciences company building predictive computer models and “virtual patients” for drug discovery and development, today announced that it has entered into a Cooperative Research and Development Agreement (CRADA) with the U.S. Food and Drug Administration’s Center for Drug Evaluation and Research (CDER).
